<DOC>
	<DOCNO>NCT01238679</DOCNO>
	<brief_summary>This study aim assess safety , tolerability , pharmacokinetics PF-04958242 number ascend dos administer 14 day healthy volunteer .</brief_summary>
	<brief_title>Multiple Dose Tolerance Study For PF-04958242</brief_title>
	<detailed_description>A decision make terminate B1701002 study emerge data study preclinical study rat could examine incorporated new study design protocol .</detailed_description>
	<criteria>male female nonchildbearing capacity No medical , neurological psychiatric illness</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>healthy volunteer</keyword>
</DOC>